ARCHIVES

ODAC Recommends Femara Campath For FDA Approval.

This article is from The Cancer Letter archive.

Vol. 27 No. 01 | January 5, 2001

Download PDF Visit The Full Archive

Related Articles

DCT Board Agrees To Use Of Program Announcement For New Surgery Grants

March 13, 1981

In Brief: FDA commissioner Kessler To Resign, Says His Goals Were Accomplished

November 29, 1996

In Brief: NCI To Leave Blair, Landlow Building; House To Hold Hearings March 5 On NCI’s 1998 Budget

February 13, 1987

OMB Reprogramming Ban Criticized

September 20, 1985

In Brief Yale Cancer Center Begins Reorganization, Names New Deputy Director, Prevention Chief

January 6, 1995

Includes May issue of Business & Regulatory Report.

May 31, 2002